AnalysisNews

TELO today

$0.36-$0.08 (-17.24%)close Nov 20, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bearish

1 hourStrong Bearish

15 minSymmetric Triangle

5 minStrong Bearish

Daily trend turns up above $1.50

Key levels

Resistance$1.07

Resistance$0.96

Latest news & SEC filings

DealTelo Genomics to Raise Funds via Secured Convertible Debentures

DealTelo Genomics Reaches Preliminary Deal to License AI Tech Exclusively

ProductTelomir Pharmaceuticals taps Linical for Telomir-Zn Phase 1/2 study

All TELO news →

About Telomir Pharmaceuticals

Telomir Pharmaceuticals develops experimental small-molecule drugs aimed at the underlying biology of aging and related illnesses. Its main candidate, Telomir-1, is taken by mouth and is intended to control levels of metals such as iron and copper inside cells; it is being tested in laboratory and animal models for Wilson's disease, Type 2 diabetes, macular degeneration, progeria, and several cancers. The firm is based in the United States and has not yet started testing in people.

Based on the company's 10-K filed Mar 17, 2026.

Nasdaq · Healthcare

Telomir Pharmaceuticals, Inc. (TELO)

$0.36-0.08 (-17.24%)
WATCHLISTGrade: B+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
0.510.660.810.950.36Oct 20Oct 28Nov 5Nov 13
High0.44
Low0.35
Open0.43
Volume247K
Avg Vol137K
VWAP0.40
30d High1.10
30d Low0.36
30d Chg-66.91%

What Is the Price Target for TELO?

SEPT Low Target

$4.00

SEPT Mid Target

$4.00

SEPT High Target

$4.00

Analyst Consensus

$4.00

Current: $0.37Upside: +972.4%Confidence: 40%Method: Analyst Consensus

Is TELO a Buy or Sell Right Now?

67
Investability Score
WATCHLIST12-18 months

Thesis

    Test your own strategy on TELO

    Describe your strategy in plain words, then scan, alert, backtest and paper trade it on TELO with SEPT’s own market data.

    Start Free Trial →

    Is TELO Overvalued or Undervalued?

    Valuation Verdict

    UNDERVALUED

    Methods Used

    P/B, Analyst Consensus

    Fair Value

    $3.05

    12

    Moat Score

    NONE

    4/9

    Piotroski Score

    4.8

    Altman Z-Score

    What Is Smart Money Doing with TELO?

    Insider Signal

    NEUTRAL

    0 buys / 0 sells (90d)

    Congress Signal

    NEUTRAL

    0 buys / 0 sells (90d)

    Institutional

    N/A

    Short Squeeze Risk

    MEDIUM

    Signal: NEUTRAL

    Track Smart Money Across 4,000+ Stocks

    Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

    See Smart Money Data →

    TELO Growth Story

    Revenue YoY

    N/A%

    3yr Revenue CAGR

    N/A%

    EPS Growth YoY

    41.07%

    FCF Growth YoY

    N/A%

    Revenue Trend

    UNKNOWN

    Dark Pool Trades for TELO

    PREVIEW

    Recent off-exchange (dark pool) prints for TELO: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.

    TimePriceSizeValueSide
    20:59:43$0.375,000$$2KBUY
    20:59:20$0.362,500$$911BUY
    20:59:14$0.362,475$$886SELL
    20:37:25$0.443,000$$1KBUY
    20:19:51$0.383,200$$1KBUY

    5 dark pool trades shown · $$6K preview volume

    Real-time institutional flow, block trades, and net positioning

    See all dark pool activity

    Full AI Research Report

    SEPT's Trading AI has generated a free, downloadable PDF research report for Telomir Pharmaceuticals, Inc. (TELO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

    Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

    Your strategy, tested before real money.

    Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.

    Try SEPT Free for 7 Days →

    TELO — frequently asked questions

    What is TELO stock price today?

    Telomir Pharmaceuticals, Inc. (TELO) is at $0.36, down 17.24% (-$0.08) at the Nov 20, 2026 close.

    Why is TELO stock moving today?

    Latest TELO news — Nov 21, 2026: Telo Genomics to Raise Funds via Secured Convertible Debentures · Nov 19, 2026: Telo Genomics Reaches Preliminary Deal to License AI Tech Exclusively

    What is the TELO price target?

    The average analyst price target for TELO is $4.00, ranging from $4 to $4, based on 1 analysts. Latest: Maxim Group initiates on Sep 17, 2026.

    What do analysts rate TELO?

    Analyst ratings for TELO: 0 Buy, 1 Hold, 0 Sell — consensus Hold.

    Did TELO beat earnings?

    TELO last reported on Aug 13, 2026: EPS -$0.79 vs -$0.07 expected — a miss of 1028.6%.

    What are TELO support and resistance levels?

    Resistance: $0.96, $1.07, $1.20.

    What are insiders doing with TELO?

    Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

    What is the latest news on TELO?

    Nov 21, 2026: Telo Genomics to Raise Funds via Secured Convertible Debentures · Nov 19, 2026: Telo Genomics Reaches Preliminary Deal to License AI Tech Exclusively · Nov 18, 2026: Telomir Pharmaceuticals taps Linical for Telomir-Zn Phase 1/2 study